Hoth Therapeutics, Inc. (HOTH) a New York-based biopharmaceutical company, Friday announced that it has been notified by Nasdaq's Listing Qualifications Department that it has regained compliance with the minimum bid price requirement outlined in Listing Rule 5550(a)(2).
The notification comes as the company's common stock maintained a closing bid price of $1.00 or higher for 10 consecutive business days, from January 7 to January 22, 2025.
Currently, HOTH is trading at $1.518 or 3.2720 percent higher on the Nasdaq Capital Market.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.